Hedgehog Signal Inhibitor GANT61 Inhibits the Malignant Behavior of Undifferentiated Hepatocellular Carcinoma Cells by Targeting Non-Canonical GLI Signaling
The Hedgehog (HH)–GLI pathway plays an important role in cell dedifferentiation and is therefore pivotally involved in the malignant transformation of cancer cells. GANT61, a selective inhibitor of GLI1 and GLI2, was reported as a promising treatment for cancer in various tissues; however, the biolo...
Main Authors: | Kensuke Harada, Ryuya Ohashi, Kyoko Naito, Keita Kanki |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/9/3126 |
Similar Items
-
Chemical, computational and functional insights into the chemical stability of the Hedgehog pathway inhibitor GANT61
by: Andrea Calcaterra, et al.
Published: (2018-01-01) -
Signaling Switching from Hedgehog-GLI to MAPK Signaling Potentially Serves as a Compensatory Mechanism in Melanoma Cell Lines Resistant to GANT-61
by: Nikolina Piteša, et al.
Published: (2023-05-01) -
Sonic Hedgehog Signature in Pediatric Primary Bone Tumors: Effects of the GLI Antagonist GANT61 on Ewing’s Sarcoma Tumor Growth
by: Mathilde Mullard, et al.
Published: (2020-11-01) -
GANT61 and Lithium Chloride Inhibit the Growth of Head and Neck Cancer Cell Lines Through the Regulation of GLI3 Processing by GSK3β
by: Vedran Zubčić, et al.
Published: (2020-09-01) -
Involvement of hedgehog pathway in early onset, aggressive molecular subtypes and metastatic potential of breast cancer
by: Syeda Kiran Riaz, et al.
Published: (2018-01-01)